Clinical Trial Update: Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neoadjuvant intra-tumor double immunotherapy for hepatocellular carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Hepatic Cancer, Surgery | Phase 2 | Status: RECRUITING